Cargando…

Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV

Antiretroviral therapy (ART) induces persistent suppression of HIV-1 replication and gradual recovery of T-cell counts, and consequently, morbidity and mortality from HIV-related illnesses have been significantly reduced. However, in approximately 30% of people living with HIV (PLHIV) on ART, CD4(+)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espineira, Sonia, Flores-Piñas, Marina, Chafino, Silvia, Viladés, Consuelo, Negredo, Eugenia, Fernández-Arroyo, Salvador, Mallolas, Josep, Villar, Beatriz, Moreno, Santiago, Vidal, Francesc, Rull, Anna, Peraire, Joaquim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465175/ https://www.ncbi.nlm.nih.gov/pubmed/37649488 http://dx.doi.org/10.3389/fimmu.2023.1228795

Ejemplares similares

Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
por: Yeregui, Elena, et al.
Publicado: (2022)

Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation
por: Masip, Jenifer, et al.
Publicado: (2022)

High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients
por: Yeregui, Elena, et al.
Publicado: (2020)

IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status
por: Ceausu, Andra, et al.
Publicado: (2019)

A baseline metabolomic signature is associated with immunological CD4(+) T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients
por: Rodríguez-Gallego, Esther, et al.
Publicado: (2018)

Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
por: Tarancon-Diez, Laura, et al.
Publicado: (2019)

Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery
por: Sánchez, Alba, et al.
Publicado: (2023)

Differential miRNA plasma profiles associated with the spontaneous loss of HIV‐1 control: miR‐199a‐3p and its potential role as a biomarker for quick screening of elite controllers
por: Masip, Jenifer, et al.
Publicado: (2021)

Fucosylated N-glycans as early biomarkers of COVID-19 severity
por: Paton, Beatrix, et al.
Publicado: (2023)

Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio
por: Tarancon-Diez, Laura, et al.
Publicado: (2023)

The People Living with HIV (PLHIV) Resilience Scale: Development and Validation in Three Countries in the Context of the PLHIV Stigma Index
por: Gottert, A., et al.
Publicado: (2019)

HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015)

Leveraging mHealth for the Treatment and Management of PLHIV
por: Kruse, Clemens Scott, et al.
Publicado: (2023)

Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in Italy
por: Cingolani, Antonella, et al.
Publicado: (2022)

Effect of TNF-α genetic variants and CCR5Δ32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards
por: Veloso, Sergi, et al.
Publicado: (2010)

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes
por: Reverté, Laia, et al.
Publicado: (2022)

Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control
por: Masip, Jenifer, et al.
Publicado: (2022)

Smokeless tobacco use and oral potentially malignant disorders among people living with HIV (PLHIV) in Pune, India: Implications for oral cancer screening in PLHIV
por: Marbaniang, Ivan, et al.
Publicado: (2022)

1274. Implementation of Pharmacist-led Medication Reconciliation in Older PLHIV
por: Karris, Maile Y, et al.
Publicado: (2022)

Association between lipid genetic and immunological status in chronically HIV-infected patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Evolution of Serum Acute-Phase Glycoproteins Assessed by (1)H-NMR in HIV Elite Controllers
por: Malo, Ana-Irene, et al.
Publicado: (2021)

Mixed infection by Cryptococcus neoformans and Cryptococcus gattii and coinfection with paracoccidioidomycosis in PLHIV
por: de Faria Ferreira, Marcela, et al.
Publicado: (2022)

Frailty status and associated factors among older PLHIV in Southern Ethiopia
por: Woldesemayat, Endrias Markos, et al.
Publicado: (2023)

Multi-Omics Approaches in Immunological Research
por: Chu, Xiaojing, et al.
Publicado: (2021)

Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia
por: Wesen, Amenu, et al.
Publicado: (2012)

Mitochondrial Functions Are Compromised in CD4 T Cells From ART-Controlled PLHIV
por: Zhao, Juan, et al.
Publicado: (2021)

The predictors of unsuppressed viremia among PLHIV: a cross-sectional study in Ghana
por: Owusu, Lydia Boampong, et al.
Publicado: (2023)

Glycoprotein Profile Assessed by (1)H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study
por: Malo, Ana-Irene, et al.
Publicado: (2020)

Only connect – the role of PLHIV group networks in increasing the effectiveness of Ugandan HIV services
por: Hodgson, Ian, et al.
Publicado: (2012)

Clinico epidemiological profile of HIV - TB coinfection among PLHIV in coastal south India
por: Bhaskaran, Unnikrishnan
Publicado: (2014)

Development and validation of PozQoL: a scale to assess quality of life of PLHIV
por: Brown, Graham, et al.
Publicado: (2018)

Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an Insight
por: S, Fathima A., et al.
Publicado: (2022)

CD4 + Count: a Variable to Be Considered to Prioritize COVID-19 Vaccination in PLHIV
por: Mounika, Vakada Lakshmi, et al.
Publicado: (2023)

Trends and factors associated with initiation of HIV treatment among PLHIV in Jamaica, 2015–2019
por: Cushnie, Anya, et al.
Publicado: (2023)

Applications of Single-Cell Omics in Tumor Immunology
por: Liu, Junwei, et al.
Publicado: (2021)

Drivers of treatment change in PLHIV- psycho-social factors are more important than considerations of adherence
por: Pitts, Marian, et al.
Publicado: (2012)

Prevalence and Associated Factors of Depression among PLHIV in Ethiopia: Systematic Review and Meta-Analysis, 2017
por: Amare, Tadele, et al.
Publicado: (2018)

Clinical features and outcome of COVID-19 among PLHIV in Gujarat, India: A case series
por: Patel, Parimal, et al.
Publicado: (2021)

Fostering Resilient Health Systems in India: Providing Care for PLHIV Under the Shadow of COVID-19
por: Parikh, Neha, et al.
Publicado: (2022)

Determination of the potency of a novel saw palmetto supercritical CO(2) extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system
por: Pais, Pilar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3vfhog8o7nt33a6ggo8qmvpouq